Hikma Pharmaceuticals PLC HKMPY
47.75 USD 0.00 (+0.00%)
At closeNov 5, 2026, 4:00 PM EST
46.68 Day range 46.68
31.80 52-week range 47.75
- YTD
- +13.88%
- 1 year
- +1.60%
News
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Q3 2026 Sales/Trading Call Transcript Hikma Pharmaceuticals PLC (HKMPY) Q3 2026 Sales/Trading Call Transcript
marketbeat.com Hikma Pharmaceuticals Raises Profit Floor as Branded Growth Offsets Injectables Slowdown Hikma Pharmaceuticals LON: HIK maintained its 2026 revenue growth outlook and narrowed its operating profit guidance as stronger performance in its Branded business helped offset a…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Discusses R&D Vision and Expansion in Respiratory, Nasal, Semi-Solids and Liquid Platforms Transcript Hikma Pharmaceuticals PLC (HKMPY) Discusses R&D Vision and Expansion in Respiratory, Nasal, Semi-Solids and Liquid Platforms Transcript
marketbeat.com Hikma Pharmaceuticals Spotlights R&D Shift, Nasal Epinephrine Filing Progress Hikma Pharmaceuticals LON: HIK outlined a more centralized research and development strategy at the first event in its R&D Spotlight series, highlighting investments in respiratory, nasal, semi-solid…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Transcript Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Transcript
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Prepared Remarks Transcript Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Prepared Remarks Transcript
prnewswire.com Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on today's unanimous…
globenewswire.com Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio - Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Bedford, and other…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
reuters.com UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that, while it has faced some pressure on shipping, energy, and insurance costs due to the war in the Middle East, a…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Prepared Remarks Transcript Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript
prnewswire.com Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US Ready-to-use sepsis therapy marks new advancement in time-critical treatment LONDON , Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today…
proactiveinvestors.co.uk Hikma Pharmaceuticals: Due a dose of confidence After a rough six months in which its shares have shed a quarter of their value, Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) looks ready for a rebound. Panmure Liberum thinks the sell-off is…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript Hikma Pharmaceuticals PLC (OTCPK:HKMPY) Shareholder/Analyst Call November 6, 2025 4:30 AM EST Company Participants Riad Mishlawi - Interim Head of Injectables Business, CEO & Director Khalid Nabilsi…
defenseworld.net Hikma Pharmaceuticals (OTCMKTS:HKMPY) Shares Up 0.9% – Should You Buy? Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY - Get Free Report) shot up 0.9% on Friday. The stock traded as high as $48.96 and last traded at $48.96. 332 shares changed hands during mid-day trading, a…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali…
seekingalpha.com Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Q&A Earnings Call August 7, 2025 4:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali Mishlawi - CEO &…
reuters.com Hikma Pharmaceuticals tumbles after injectables margin outlook cut Shares of Hikma Pharmaceuticals fell as much as 10% on Thursday after a strong euro prompted the group to lower margin outlook for its injectables unit, despite beating expectations for overall…
prnewswire.com Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON , July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company,…
prnewswire.com Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines Next phase builds on 34+ years of serving the needs of US patients and healthcare providers COLUMBUS, Ohio , June 28, 2025 /PRNewswire/ -- In its ongoing mission to help meet America's growing need…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday